Oriol Calvete

7PUBLICATIONS
63CO-AUTHORS
Predictive and prognostic markersInfant and child healthMedical biotechnology diagnostics (incl. biosensors)Gene and molecular therapyFree radical chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 10, 2026
Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms.

|Feb 13, 2025
Prenatal and Perinatal Factors Associated with Infant Acute Lymphoblastic Leukaemia: A Scoping Review.

Arantza Sanvisens, Clara Bueno, Oriol Calvete

|Oct 17, 2024
Beyond myeloid neoplasms germline guidelines: Validation of the thresholds criteria in the search of germline predisposition variants.

Julia Mestre, Lorea Chaparro, Ana Manzanares

|Dec 23, 2023
Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms.

Oriol Calvete, Julia Mestre, Ruth M Risueño

|Jan 31, 2023
Are the current guidelines for identification of myelodysplastic syndrome with germline predisposition strong enough?

Oriol Calvete, Julia Mestre, Arda Durmaz

|Jun 23, 2022
Small-molecule activation of OGG1 increases oxidative DNA damage repair by gaining a new function.

Maurice Michel, Carlos Benítez-Buelga, Patricia A Calvo

Pageof 2

Frequent Collaborators

4 joint publications

Francesc Solé

3 joint publications

Julia Mestre

2 joint publications

Blanca Xicoy

2 joint publications

Lurdes Zamora